Abstract
The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.
| Original language | English |
|---|---|
| Journal | Med (New York, N.Y.) |
| Volume | 3 |
| Issue number | 8 |
| Pages (from-to) | 531-537 |
| Number of pages | 7 |
| ISSN | 2666-6340 |
| DOIs |
|
| Publication status | Published - 12 Aug 2022 |
Keywords
- COVID-19/prevention & control
- COVID-19 Vaccines
- Humans
- Inpatients
- Randomized Controlled Trials as Topic
- Vaccination/methods
Fingerprint
Dive into the research topics of 'Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS